title: Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
authors.forename: Hannele
authors.initials: H
authors.lastname: Heikkilä
authors.forename: Annamari
authors.initials: A
authors.lastname: Ranki
authors.forename: Suvi
authors.initials: S
authors.lastname: Cajanus
authors.forename: Seija-Liisa
authors.initials: SL
authors.lastname: Karvonen
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003873:Dermatitis, Exfoliative / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab; D008727:Methotrexate